journal
MENU ▼
Read by QxMD icon Read
search

P & T: a Peer-reviewed Journal for Formulary Management

journal
https://www.readbyqxmd.com/read/29386870/research-briefs
#1
(no author information available yet)
No abstract text is available yet for this article.
February 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29386869/new-antibiotics-in-development-target-highly-resistant-gram-negative-organisms
#2
Troy Kish
Upcoming antibacterial agents in the pipeline appear promising, but it is difficult to predict their long-term durability. This article focuses on investigational agents that target resistant gram-negative organisms commonly found in the health care setting.
February 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29386868/american-society-of-hematology
#3
Walter Alexander
We review key sessions on Hodgkin's lymphoma, diffuse large B-cell lymphoma, thromboembolism, hemophilia, sickle cell disease, and chronic lymphocytic leukemia.
February 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29386867/impact-of-a-pharmacy-led-medication-reconciliation-program
#4
Naomi Digiantonio, Jeremy Lund, Samantha Bastow
Objective: To determine the impact of a pharmacy-led medication reconciliation program at a large community hospital. The magnitude of the benefit of pharmacy-led medication reconciliation was evaluated based on the number of medication-related discrepancies between nursing triage notes and medication histories performed by pharmacy technicians or students. Discrepancies identified by pharmacy personnel medication histories that required pharmacist intervention on physician admission orders were further classified based on expected clinical impact if the error were to be propagated throughout hospitalization...
February 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29386866/osteoporosis-a-review-of-treatment-options
#5
Kristie N Tu, Janette D Lie, Chew King Victoria Wan, Madison Cameron, Alaina G Austel, Jenny K Nguyen, Kevin Van, Diana Hyun
Approximately 10 million men and women in the U.S. have osteoporosis,1 a metabolic bone disease characterized by low bone density and deterioration of bone architecture that increase the risk of fractures.2 Osteoporosis-related fractures can increase pain, disability, nursing home placement, total health care costs, and mortality.3 The diagnosis of osteoporosis is primarily determined by measuring bone mineral density (BMD) using noninvasive dual-energy x-ray absorptiometry. Osteoporosis medications include bisphosphonates, receptor activator of nuclear factor kappa-B ligand inhibitors, estrogen agonists/antagonists, parathyroid hormone analogues, and calcitonin...
February 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29386865/talk-of-a-default-drug-formulary-rattles-industry-cms-could-move-in-that-direction-for-marketplace-plans-after-2019-but-the-discussion-has-already-started
#6
Stephen Barlas
A proposed CMS rule promising to consider a federal default prescription drug benefit after 2019 has startled manufacturers, pharmacy benefit managers, P&T committees, and pharmacies alike. We consider the rationale and potential effects of such a rule.
February 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29386864/betrixaban-bevyxxa-a-direct-acting-oral-anticoagulant-factor-xa-inhibitor
#7
Jessica W Skelley, Angela R Thomason, Jeffery C Nolen, PharmD Candidate
Betrixaban (Bevyxxa): a direct-acting oral anti-coagulant factor Xa inhibitor.
February 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29386863/pharmaceutical-approval-update
#8
Michele B Kaufman
Benznidazole for pediatric patients with Chagas disease; vestronidase alfa-vjbk (Mepsevii) for adults and children with mucopolysaccharidosis type VII; and hepatitis B vaccine (recombinant), adjuvanted (Heplisav-B), for the prevention of infection caused by all known subtypes of hepatitis B virus in adults.
February 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29386862/drug-and-device-news
#9
(no author information available yet)
Approvals, new indications, regulatory activities, and more.
February 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29386861/cms-considering-pharmacy-counter-discounts-for-part-d-drugs-in-future-other-pharmacy-changes-are-likely-for-2019
#10
Stephen Barlas
CMS considering pharmacy counter discounts for Part D drugs in the future.
February 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29386860/the-absence-of-a-drug-disease-interaction-alert-leads-to-a-child-s-death
#11
Matthew Grissinger
The absence of a drug-disease interaction alert leads to a child's death.
February 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29290678/research-briefs
#12
(no author information available yet)
No abstract text is available yet for this article.
January 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29290677/clinical-relevance-and-cost-savings-of-levocarnitine-versus-ammonul-in-the-management-of-hyperammonemia-in-a-cancer-patient-the-impact-of-a-clinical-pharmacist
#13
Chukwuma Anyanwu, Chinonso Ezeudu, Hoa Le, Oliver Egwim
Background: Hyperammonemia, a relatively uncommon condition characterized by elevated ammonia levels in the blood, presents with varied physiological etiologies that may send patients to the intensive care unit (ICU) with encephalopathy. An immediate decrease in ammonia levels is necessary to avert neurological damage. However, due to the multifaceted nature of hyperammonemia, a definite determination of etiology is not always possible. Objective: This case report examines the clinical and economic impact of a pharmacist in managing acute hyperammonemia of unknown etiology in a 62-year-old Hispanic man who had recently been diagnosed with metastatic medullary thyroid cancer and associated hypercalcemia...
January 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29290676/american-heart-association
#14
Walter Alexander
We review key sessions from the 2017 AHA Scientific Sessions that included pharmacological aspects of treatment for peripheral artery disease, type-2 diabetes, percutaneous coronary intervention, atrial fibrillation, and hypertension.
January 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29290675/despite-gains-the-war-on-hiv-is-far-from-over-with-no-cure-in-sight-experts-urge-early-diagnosis-and-prompt-treatment-with-better-adherence
#15
Susan L Worley
Although a significant increase in life expectancy for people with human immunodeficiency virus was reported last spring, experts in the U.S. caution that the results are not a cause for complacency. Efforts to develop a vaccine and a cure remain essential, as do efforts to develop interventions that may improve adherence.
January 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29290674/regulatory-change-versus-legislation-impacting-health-care-decisions-and-delivery
#16
F Randy Vogenberg, Mary Smart
Despite the president's urging, congressional efforts to repeal the Patient Protection and Affordable Care Act (PPACA) have been repeatedly unsuccessful. The authors explore key actions taken by the administration and department heads that have resulted in delayed enforcement of the PPACA and relaxation of the law.
January 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29290673/vertical-integration-heats-up-in-drug-industry-will-medication-price-hikes-cool-down-as-a-result
#17
Stephen Barlas
Is industry consolidation a response to President Donald Trump's repeated denunciation of high drug prices and congressional hearings on the issue? The author considers whether any of this corporate collaboration will get at some of the significant, underlying problems in the drug-pricing space.
January 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29290672/edaravone-radicava-a-novel-neuroprotective-agent-for-the-treatment-of-amyotrophic-lateral-sclerosis
#18
Martin Paspe Cruz
Edaravone (Radicava): a novel neuroprotective agent for the treatment of amyotrophic lateral sclerosis.
January 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29290671/pharmaceutical-approval-update
#19
Michele B Kaufman
Latanoprostene bunod ophthalmic solution (Vyzulta) for the reduction of intraocular pressure; letermovir (Prevymis) for prophylaxis of cytomegalovirus infection and disease after stem cell transplant; benralizumab (Fasenra) for the add-on maintenance treatment of severe asthma of an eosinophilic phenotype.
January 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29290670/drug-and-device-news
#20
(no author information available yet)
Approvals, new indications, regulatory activities, and more.
January 2018: P & T: a Peer-reviewed Journal for Formulary Management
journal
journal
30579
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"